Interim results from clinical trials suggested that Covaxin could be safe and effective, potentially removing one hurdle to New Delhi’s ambitious campaign to inoculate a vast population.
source https://www.nytimes.com/2021/03/04/world/asia/india-coronavirus-vaccine-covaxin.html
0 Comments